Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery
Grewal Eye Institute
This study analyzes the safety and efficacy of off-label Subconjunctival Injection of
bevacizumab (Avastin) versus 0.02% mitomycin C (MMC) for preventing bleb failure following
glaucoma filtration surgery.
The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A
Assistance Publique - Hôpitaux de Paris
Second line treatment for detrusor hyperreflexia is the intravesical BTX-A injections. First
300 units Botox are diluted with 30 ml of preservative-free saline. Using a rigid cystoscope
and an injection needle, BTX-A is injected into 30 sites within the detrusor muscle.
The used of KALINOX® (50% nitrous oxide and oxygen) inhalation has demonstrated analgesic
efficacy in various procedures (obstetric, liver biopsy, transrectal ultrasound guided
prostate biopsy, emergency) The aim of this study is to investigate the safety and efficacy
of analgesia with N2O/O2 inhalation for detrusor BTX-A injections using a rigid cystoscope.
Evaluation of Deep Topical Fornix Nerve Block Versus Topical Anaesthesia Procedure
General anaesthesia now a days is not the first choice in phakic intra ocular lens surgery
(Phakic IOL) , the short duration of the surgery, general anaesthesia complications, decrease
the length of hospital stay and decreasing the costs direct the interest to the regional
anaesthesia By the time the traditional retro and peribulbar injections recede to a newer
techniques that is safer and cheaper, sub tenon's block using a blunt needle took over due to
the more safety profile Even though, still serious problems can occur specially in patients
with long axial length.
Deep topical fornix nerve block anaesthesia (DTFNB) and topical anaesthesia gradually took
over with promising and successful results, decreasing length of hospital stay and increasing
patient satisfaction and fewer margins of complications.
In this study the investigators compared topical anaesthesia alone with DTFNBA in patients
undergoing posterior chamber phakic IOL surgery (Visian ICL).
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.